Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Journal of the International AIDS Society
Published in: Journal of the International AIDS Society 4/2010

Open Access 01-12-2010 | Poster presentation

Prevalence and factors associated with severe vitamin D deficiency in HIV/hepatitis C co-infected patients

Authors: S Surah, A Samarawickrama, L Campbell, R Kulasegaram, F Post, M Fisher, B Peters, J Fox

Published in: Journal of the International AIDS Society | Special Issue 4/2010

Login to get access

Excerpt

Vitamin D deficiency (VDD) is associated with elevated risks of cardiovascular disease, malignancies and impaired survival of the general population. In HIV infection VDD is related to anaemia, HIV disease progression and death, and in hepatitis C (HCV) infection impaired treatment responses to interferon. Severe VDD is common in both HIV and HCV mono-infection. The prevalence of VDD in HIV/HCV co-infected patients, and the effect of the severity of liver disease on vitamin D status remains unknown. The aim of this study was to investigate the prevalence of, and factors linked to severe VDD in HIV/HCV co-infected patients. …
Metadata
Title
Prevalence and factors associated with severe vitamin D deficiency in HIV/hepatitis C co-infected patients
Authors
S Surah
A Samarawickrama
L Campbell
R Kulasegaram
F Post
M Fisher
B Peters
J Fox
Publication date
01-12-2010
Publisher
BioMed Central
DOI
https://doi.org/10.1186/1758-2652-13-S4-P103

Other articles of this Special Issue 4/2010

Journal of the International AIDS Society 4/2010 Go to the issue

Poster presentation

Influence of demographic and disease parameters on virological response to once- vs twice-daily darunavir/ritonavir (DRV/r) at week 48 in ODIN

Oral presentation

0221. The clinical development of NRTIs — cautionary tales

Poster presentation

Kidney tubular function and serum phosphate levels in HIV-1-infected patients treated with tenofovir: preliminary results

Poster presentation

Cost-efficacy analysis of the MONET trial using Spanish antiretroviral drug prices

Poster presentation

Salvage therapy with raltegravir in a 3-month-old infant

Oral presentation

0315. The pharmacokinetic and safety profile of raltegravir and ribavirin, when dosed separately and together, in healthy volunteers
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits